期刊文献+

步行试验对老年慢性心力衰竭患者运动耐量的评估 被引量:6

Assessment of walking test on exercise tolerance in elderly patients with chronic heart failure
原文传递
导出
摘要 目的 :探讨 6min步行试验 (6MWT)对老年慢性心力衰竭 (CHF)患者运动耐量的评价。方法 :将 5 4例CHF患者随机分为常规治疗组 (n =2 5 )和卡维地洛组 (n =2 9) ,治疗前后进行步行试验 ,监测肿瘤坏死因子(TNF α)、白细胞介素 6 (IL 6 )、去甲肾上腺素 (NE)和左室射血分数 (LVEF)。结果 :心功能Ⅳ级患者较Ⅱ级患者步行距离明显下降 (P <0 .0 1) ,Ⅲ级与Ⅱ级、Ⅳ级与Ⅲ级患者之间步行距离的差异无显著性意义 (P >0 .0 5 ) ;卡维地洛组 6min步行距离治疗前后差异有显著性意义 (P <0 .0 1) ,而常规治疗组差异无显著性意义 (P >0 .0 5 ) ,两组患者步行距离与TNF α、IL 6、NE呈显著负相关 (P <0 .0 5 ) ,与LVEF呈正相关 (P <0 .0 5 )。结论 :6MWT具有简单、易行、安全、可靠的特点 ,可作为评估CHF患者运动耐量的临床工具 ,尤其适用于老年患者 。 Objective:To assess 6-minute walking test(6MWT) on exercise tolerance in elderly patients with chronic heart failure. Methods:Fifty four patients with chronic heart failure were divided into two groups at random. In the routine group (n=25), patients were treated by ACE inhibitors, diuretics and digoxin, and in the carvedilol group (n=29) treated by ACE inhibitors,diuretics, digoxin and carvedilol. All patients underwent 6MWT before and after the treatment.At the same time, The plasma concentration of TNF α, IL 6 and NE were measured. LVEF was also detected. Results:Compared with the patients in New York Heart Association(NYHA) class Ⅱ, 6MWTdistance in the patients in NYHA class Ⅳ was significantly decreased [( 345.00 ± 48.56 )m vs ( 369.00 ± 52.15 )m, P< 0.01 ]. But there was no difference either between NYHA class Ⅲ and NYHA classⅡ or between NYHA class Ⅲ and NYHA class Ⅳ. There was significant difference on 6MWT distance covered before and after the treatment in the carvedilol group (P< 0.01 ), but there was no difference in the routine group (P> 0.05 ). Meanwhile, 6MWT distance covered was negatively correlated with TNF α, IL 6 and NE (r= -0.62 , -0.59 , -0.60 , respectively P< 0.05 ), but positively correlated with LVEF (r= 0.63 , P< 0.05 ). Conclusion:6 MWT is a simple, inexpensive, safe and reproducible means of assessing exercise tolerance in chronic heart failure especially for the elderly patients. It can also provide a clinical test to judge the curative effect and prognosis.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2003年第10期601-603,共3页 Journal of Clinical Cardiology
关键词 心力衰竭 充血性 6分钟步行试验 运动耐量 Heart failure, congestive 6 minute walking test Exercise tolerance
  • 相关文献

参考文献10

  • 1姜红,戴闺柱.心力衰竭患者心功能的评定──6分钟步行试验与运动峰耗氧量对比研究[J].临床心血管病杂志,1995,11(5):270-272. 被引量:12
  • 2Guyatt G H, Sullivan M J, Thompson P J, et al. The six minute walk: A new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J, 1985, 132: :919-923.
  • 3Conley K E, Esselman P C, Jubrias S A, et al. Aging, muscle properties and maximal 02 uptake rate in humans. J Physiol, 2000,526:211-217.
  • 4Forissier J F, Vemochet P, Bertrand P, et al. Influence of carvedilol on the benefits of physical training in patients with moderate chronic heart failure. Eur J Heart Fail, 2001, 3:335-342.
  • 5Butland R J A, Pang J, Gross E R, et al. Two- ,sixand 12-minute walking test in respiratory disease. Br Med J ,1982,284:1607-1608.
  • 6Cahalin L P, Mathier M A, Semigran M J, et al. The six minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest, 1996, 110:325-332.
  • 7Faggiano P, D'Aloia A, Gualeni A, et al. Assessment of oxygen uptake during the six minute walk test in patients with heart failure. Preliminary experience using a portable device. Am Heart J, 1997, 134 : 203- 206.
  • 8Lommi J, Pulkkit K, et al. Haemodynamic, neuroendocrin and metabolic correlates of circulating cytokine concentration in congestive heart failure. Eur Heart J, 1997,18 : 1620- 1625.
  • 9Feffari R, Bachetti T, Confortini R I, et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure . Circulation, 1995,2: 1479-1486.
  • 10Magowan G A, Mann D L, Kormos R L, et al. Circulating interleukin-6 in severe heart failure. Am J Cardiol, 1997, 79:1128-1130.

共引文献11

同被引文献56

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部